Acute Myeloid Leukemia (AML) represents a significant public health concern globally, with its prevalence and incidence on the rise. According to the American Cancer Society’s estimates for 2025, approximately 22K people in the United States are expected to be diagnosed with AML, with most cases occurring in adults. The disease is notably severe, as around 11K individuals are projected to die from AML in the same year, again predominantly affecting adults. While AML accounts for about 1 out of 3 leukemias in adults, it remains relatively uncommon overall, constituting about 1% of all cancers. The average age at diagnosis is approximately 69 years, and while AML can oc...
